Holoprosencephaly 11 is a rare genetic condition that affects how the front of the brain and face form before birth. Features can include closely spaced eyes, cleft lip or palate, feeding problems, seizures, and developmental delay. Signs are usually recognized during pregnancy or in infancy, and the condition is lifelong. Outcomes vary widely, and severe forms can be life‑limiting while milder forms may allow survival into childhood or adulthood. Care focuses on supportive treatments like feeding support, seizure control, therapies, and coordinated specialist care.
Overview
Holoprosencephaly 11Symptoms
Holoprosencephaly 11 features vary widely, often recognized on prenatal ultrasound. Signs include poor separation of the brain, facial differences such as close-set eyes or cleft lip/palate, feeding or breathing problems, seizures, and developmental delay. Some have learning problems.
Outlook and prognosis
Holoprosencephaly 11 varies widely. Some babies have severe brain and facial differences and may not survive the newborn period, while others live into childhood with significant developmental and medical needs. Care focuses on seizures, feeding, breathing, hormones, and supportive therapies.
Causes and risk factors
Holoprosencephaly 11 is usually caused by a change in the CDON gene, inherited in an autosomal dominant way or arising as a new mutation. Risk and severity can be modified by maternal diabetes, certain medicines, alcohol, infections, and low folate.
Genetic influences
Genetics plays a major role in Holoprosencephaly 11; many cases stem from changes in the SHH pathway genes, including heterozygous variants. Inherited and de novo variants both occur, with variable expressivity and incomplete penetrance. Genetic counseling and testing are often recommended.
Diagnosis
Holoprosencephaly 11 is diagnosed by brain imaging plus recognizable clinical features. Genetic tests can identify a causative variant, providing a genetic diagnosis of Holoprosencephaly 11. Prenatal ultrasound or fetal MRI may show suggestive findings.
Treatment and drugs
Treatment for Holoprosencephaly 11 focuses on supportive, individualized care based on each child’s needs. Teams may use anti-seizure medicines, feeding and breathing support, hormone replacement if pituitary function is affected, and therapies to aid development. Regular monitoring and family-centered palliative supports help manage symptoms and quality of life.
Symptoms
Day to day, families often notice feeding challenges, breathing patterns, and differences in facial features or head shape in a newborn. Early features of Holoprosencephaly 11 can include difficulties with feeding, muscle tone, and development, with a wide range of severity. Features vary from person to person and can change over time. Some children have only subtle facial or dental differences, while others have significant medical needs.
The space between the eyes may be narrow, the nose or midface may look flatter, or a single front tooth may be present. Some have cleft lip or cleft palate that affects feeding and speech. These differences are common in Holoprosencephaly 11 and vary widely.
The head may be smaller than average (microcephaly) or shaped differently. Doctors may notice changes on brain imaging that explain developmental needs. These findings can be typical of Holoprosencephaly 11.
Sitting, crawling, walking, or talking can take longer. Therapies can help children build skills and communication. In Holoprosencephaly 11, progress often occurs but at a different pace.
Some babies feel very floppy, while others are stiff. This can affect rolling, balance, and coordination. Physical therapy can support strength and posture.
How people usually first notice Holoprosencephaly 11?
Parents and clinicians often first notice holoprosencephaly 11 during pregnancy when an ultrasound shows brain structures that haven’t separated as expected, sometimes along with facial differences such as closely spaced eyes, a single central front tooth, or cleft lip/palate. If not seen prenatally, the first signs of holoprosencephaly 11 may be apparent at birth or in early infancy through distinctive facial features, small head size, poor feeding, low muscle tone, seizures, or breathing problems. Genetic testing—often prompted by these findings—can confirm how holoprosencephaly 11 is first noticed and guide care for the baby and family.
Types of Holoprosencephaly 11
Holoprosencephaly 11 is a genetic form of holoprosencephaly linked to changes in the CDON gene. Different variants or subtypes are recognized by how much the developing forebrain separates, which often parallels facial features and developmental needs. Symptoms don’t always look the same for everyone. Understanding the main variants can help families and clinicians talk clearly about types of Holoprosencephaly 11 and what to expect.
Alobar type
The forebrain does not split into two halves, leading to a single, large brain cavity. This most severe form often causes profound developmental challenges, seizures, and feeding or breathing issues. Facial differences can be marked.
Semilobar type
The brain separates partially, with some division at the back but not the front. Children may have moderate to severe developmental delays and seizures. Facial differences and hormone problems can occur.
Lobar type
The brain is mostly divided into two hemispheres, with only subtle fusion in the front areas. Developmental and learning needs are usually milder than in other types but can still be significant. Seizures or hormone issues may still happen.
Middle interhemispheric variant
The brain fails to separate mainly across the middle regions rather than the front. People may have motor coordination issues, spasticity, and variable learning challenges. Facial differences may be less pronounced.
Microform spectrum
Very mild variants show subtle midline changes, sometimes with a normal-appearing brain scan. People may have small midline facial differences (like a single central incisor) and mild learning or speech difficulties. These variants of Holoprosencephaly 11 can be missed without careful evaluation.
What genetics can tell you about symptoms
Some people with Holoprosencephaly 11 have changes in the SHH gene, which can lead to the brain’s front parts not fully dividing, causing features like closely spaced eyes, a single front tooth, or a flat nasal bridge. The same change can range from severe brain differences in infants to only mild facial differences in relatives.
Causes and risk factors
Holoprosencephaly 11 is usually caused by a change in a gene called CDON. This change can happen for the first time in a child, or it can be passed from a parent. Having a gene change doesn’t mean you’ll definitely develop the condition. Known risk factors for Holoprosencephaly 11 include preexisting diabetes in the mother and exposure to alcohol or acne medicines like isotretinoin in early pregnancy. Other genes and the environment can shape how severe it is, so some relatives may have mild facial signs or none at all.
Environmental and biological risk factors
Holoprosencephaly 11 arises very early in pregnancy, so risks are tied to that brief window when the forebrain and face begin forming. Doctors often group risks into internal (biological) and external (environmental). Below are key biological and environmental risk factors for Holoprosencephaly 11 that have been reported in research and clinical experience. Not everyone exposed to these factors will have a child affected, but understanding them can help frame conversations with your care team.
High blood sugar around conception and in the first 4–6 weeks can disrupt early brain patterning. This has been linked to a higher chance of holoprosencephaly, including Holoprosencephaly 11.
Vitamin A–related acne or psoriasis medicines taken early in pregnancy can alter midline brain and face formation. Such exposures have been associated with holoprosencephaly in some reports and are a recognized pregnancy risk.
Alcohol in the first trimester can interfere with forebrain development. Risk appears highest with exposure during the earliest weeks when the brain’s midline is being set.
Non-chromosomal holoprosencephaly has been observed more often in younger mothers. This is a population trend and does not predict outcomes for any one pregnancy.
Genetic risk factors
Holoprosencephaly 11 is most often linked to harmful changes in the CDON gene, which plays a key role in early brain patterning. These changes can be inherited from a parent or occur for the first time in a child, and how they show up can vary widely even within a family. Carrying a genetic change doesn’t guarantee the condition will appear. Genetic testing is often considered when early symptoms of Holoprosencephaly 11 prompt evaluation.
CDON gene variants: Harmful changes in CDON are the primary genetic cause of Holoprosencephaly 11. They disrupt early signals that shape the midline of the brain and face. Changes that stop the gene working or alter how it works have both been reported.
Autosomal dominant pattern: One altered copy can be enough to raise risk for Holoprosencephaly 11. Risk is not destiny—it varies widely between individuals. Some relatives may have only subtle features while others have more significant differences.
De novo variants: Many children have a CDON change that arose new in the egg, sperm, or early embryo. Parents typically test negative for the variant. Recurrence risk is usually low but not zero if a parent has mosaicism.
CDON deletions: Small missing sections of DNA that include CDON can lead to Holoprosencephaly 11. These deletions remove the gene or key parts of the gene, acting like the gene is switched off. They may occur alone or alongside other nearby changes.
Combined gene changes: Extra changes in other holoprosencephaly-related genes can modify risk and severity. The combination of variants can shift outcomes from mild to severe. This pattern helps explain differences among siblings.
Parental mosaicism: A parent can carry the CDON change in a portion of their eggs or sperm without having features themselves. This hidden mosaicism can increase the chance of another affected pregnancy. Discussing recurrence risk with a genetics team can clarify options.
Variant interpretation: How a lab classifies the CDON change (clearly disease-causing, likely disease-causing, or uncertain) influences risk counseling. Changes that cut the protein short often have clearer links than small substitutions. Family studies may reclassify uncertain findings over time.
Family history: Having relatives with features on the holoprosencephaly spectrum suggests a shared genetic cause. Mild signs like a single central incisor or subtle midline differences may appear in relatives. This context can refine individual risk estimates.
Lifestyle risk factors
Lifestyle habits do not cause Holoprosencephaly 11, but they can shape day-to-day symptoms, comfort, and complications. Thoughtful routines around feeding, movement, sleep, and care can reduce preventable problems and support development. Here’s how lifestyle affects Holoprosencephaly 11 in daily life.
Calorie-dense, texture-appropriate meals can support growth and reduce fatigue during feeding. Consistent mealtimes and reflux-aware strategies may lower aspiration events and stabilize energy for therapy participation. A medically supervised ketogenic diet may help seizures in select cases.
Regular, therapist-guided movement can maintain joint range, reduce contractures, and support head-trunk control. Better motor control may improve swallowing safety and respiratory function.
Upright, well-supported positioning during and after feeds can lower reflux and aspiration risk. Safe sleep-positioning and seating systems can protect the airway and reduce pressure injuries.
Predictable bedtimes and soothing routines may decrease irritability and behavior dysregulation. Adequate, consolidated sleep can reduce seizure susceptibility in some individuals.
Risk prevention
Holoprosencephaly 11 is present from birth and most often tied to genetic changes, so there’s no guaranteed way to stop it entirely. Still, planning before and during pregnancy can lower certain risks and support early detection. Prevention is about lowering risk, not eliminating it completely. Making a plan with your clinician and a genetic counselor can help you choose options that fit your health and family goals.
A counselor can explain how Holoprosencephaly 11 can run in families and what your personal chances may be. They can outline testing options and timing before or during a future pregnancy.
If a specific family variant is known, testing parents can clarify recurrence risk for Holoprosencephaly 11. Results help tailor planning, including whether embryo or prenatal tests are useful.
Aim for a healthy weight, manage chronic conditions, and begin folic acid 400–800 micrograms (0.4–0.8 mg) daily at least 1 month before conception. Good baseline health supports fetal development and reduces preventable risks.
If you live with diabetes, tighten glucose management before conception and in early pregnancy. Well-controlled blood sugar lowers the chance of congenital anomalies linked to high glucose exposure.
Transmission
Holoprosencephaly 11 is not infectious—you can’t catch it or pass it between people through contact. Most often, it follows an autosomal dominant pattern, meaning a single gene change can be enough, but many cases happen because of a new change in the child with no family history.
If a parent carries the gene change, each pregnancy has about a 50% chance to inherit it, though not everyone who inherits it will have the same features; some relatives may have only mild facial differences or none at all. Rarely, a parent may carry the change only in some eggs or sperm, so talking with a genetics team can clarify how Holoprosencephaly 11 is inherited and the genetic transmission of Holoprosencephaly 11 in a family.
When to test your genes
Test genes when holoprosencephaly is suspected on prenatal ultrasound or MRI, or when a newborn shows features like closely spaced eyes, midline facial differences, or seizures. Genetic testing also helps if a child is diagnosed, to guide care and prognosis. Parents planning more pregnancies may consider carrier or diagnostic testing.
Diagnosis
Holoprosencephaly 11 is typically identified by how the developing brain looks on imaging, with facial features and other findings helping point to the diagnosis. In pregnancy, ultrasound and sometimes fetal MRI can show midline brain changes that raise concern and guide planning. After birth, a brain MRI and a careful physical and neurological exam usually confirm the pattern and severity. Early and accurate diagnosis can help you plan ahead with confidence.
Sonographers look for signs like fused brain chambers, absent midline structures, or a single large ventricle. Facial differences such as closely spaced eyes or a small or absent nose may also be seen. Abnormal findings usually prompt referral to a high‑risk pregnancy team.
This scan provides a clearer view of brain anatomy when ultrasound is uncertain or limited by position. It helps define the type and extent of holoprosencephaly to guide counseling and delivery planning.
Doctors check for facial features linked to holoprosencephaly and assess feeding, breathing, and muscle tone. These clinical features support what was seen on imaging and help prioritize urgent care needs.
MRI after birth confirms the brain pattern and how much the hemispheres are separated. It also looks for related changes that can affect movement, vision, or hormone control.
Stages of Holoprosencephaly 11
Holoprosencephaly 11 does not have defined progression stages. It is a difference in brain formation present before birth; severity can range widely, but the condition doesn’t usually unfold step by step over time. When early symptoms of Holoprosencephaly 11 are subtle, doctors use imaging—such as prenatal ultrasound or MRI, and after birth, brain MRI or CT—to see the brain’s structure clearly, and may add genetic testing to clarify the cause. Early and accurate diagnosis helps you plan ahead with confidence.
Outlook and prognosis
Even though it can feel overwhelming, many living with Holoprosencephaly 11 want to know what the next months and years might look like. Outlook varies widely depending on how the brain, face, and organs are affected, and whether there are complications like feeding or breathing problems. Some babies with severe forms face life‑threatening challenges in the newborn period, while others with milder changes grow into childhood and beyond with developmental delays that range from subtle learning needs to more significant support needs.
Doctors call this the prognosis—a medical word for likely outcomes. Early symptoms of Holoprosencephaly 11 can include poor feeding, low muscle tone, seizures, or delays in rolling, sitting, or talking; over time, the focus often shifts to managing seizures, supporting growth and nutrition, and helping with mobility and communication. Survival into later childhood and adulthood is possible, especially in milder forms, but the risk of early mortality is higher when there are severe brain differences, heart or breathing problems, frequent infections, or uncontrolled seizures. With ongoing care, many people maintain meaningful routines—school with supports, therapies, adaptive communication—and families often learn a steady rhythm of appointments, therapies, and home strategies.
Looking at the long-term picture can be helpful. The long-term outlook is shaped by the specific brain findings, other organ involvement, and access to coordinated care such as neurology, endocrinology, nutrition, and rehabilitation. Many people find that symptoms change over time, and care plans are adjusted—medications for seizures, feeding support if needed, vision or hearing services, and individualized education. Talk with your doctor about what your personal outlook might look like, including what to watch for, how to plan for transitions, and which supports can improve quality of life.
Long-term effects
Holoprosencephaly 11 has a wide range of long-term outcomes, from severe challenges in infancy to milder features that allow survival into adulthood. Long-term effects vary widely, and two people in the same family can be affected very differently. The outlook depends on how the brain and face developed before birth and whether seizures, hormone issues, or feeding problems occur. Families often ask about life expectancy in Holoprosencephaly 11; in general, more severe brain differences carry higher early risks, while milder forms can be compatible with long adult lives.
Severe forms carry the highest risk of serious complications in the first months to years. Milder forms of Holoprosencephaly 11 can be consistent with survival into adulthood.
Many living with Holoprosencephaly 11 have developmental delays and intellectual disability that range from mild to profound. Skills may progress over time, but often at a slower pace than peers.
Low muscle tone and movement coordination issues can persist long term. Some walk independently, while others need wheelchairs or ongoing physical support.
Seizures are common and may start in infancy or childhood. They can continue into adulthood, with patterns that vary from rare events to frequent episodes.
How is it to live with Holoprosencephaly 11?
Living with holoprosencephaly 11 can mean navigating a wide range of abilities and needs, from mild learning and speech differences to significant challenges with movement, feeding, breathing, and seizures. Daily life often revolves around coordinated care—regular therapies, medical visits, adaptive equipment, and careful attention to safety and comfort—while celebrating small milestones that matter. For family members, it can be both exhausting and deeply meaningful, with roles expanding to include advocate, care coordinator, and attentive observer of subtle changes. Many find strength in a consistent routine, a responsive medical team, and support networks that share practical tips and emotional solidarity.
Treatment and drugs
Treatment for Holoprosencephaly 11 focuses on supportive care and managing complications rather than reversing the brain differences themselves. Care is usually coordinated by a team—neurology, endocrinology, feeding and breathing specialists, physical and occupational therapy, and sometimes surgery for skull, facial, or cleft-related issues. Seizures are treated with anti-seizure medicines, hormone problems (like low sodium-regulating hormones or diabetes insipidus) may need lifelong hormone replacement, and feeding challenges can require thickened feeds or a feeding tube to ensure nutrition and prevent aspiration. Breathing support, management of reflux and constipation, spasticity treatments, and careful monitoring of growth and development are common parts of care; palliative care teams often help with comfort and care planning. Not every treatment works the same way for every person, so plans are individualized and updated over time as needs change.
Non-drug treatment
Holoprosencephaly 11 affects each child differently, so care focuses on comfort, safety, and development at home and in school. Early symptoms of Holoprosencephaly 11 can vary, which is why tailored, non-drug care plans matter. Beyond prescriptions, supportive therapies can help children gain skills, communicate needs, and participate in daily life. Teams often include therapists, surgeons, nutrition specialists, and educators working alongside families.
Therapy starts in infancy to build movement, feeding, and communication skills. Starting early can shape brain pathways and daily routines.
Guided exercises help with head control, sitting balance, and safe mobility. Stretching and positioning can prevent tight muscles and joint problems.
Practice with hand skills supports feeding, play, and self-care. Adaptive grips, seating, and daily routines make activities easier.
Speech-language therapy supports early communication, from gestures to devices. Feeding therapy and swallow training can reduce choking and improve nutrition.
Your genes may have an impact on how drugs work for you
Some medicines used in holoprosencephaly 11 can work differently depending on a person’s genes, which influence how fast drugs are processed and how strongly cells respond. Genetic results may guide dose choices or prompt alternatives to balance benefit and side effects.
Pharmacological treatments
Medicines for holoprosencephaly 11 focus on easing day-to-day problems like seizures, feeding challenges, sleep disruption, and hormone issues, since there’s no drug that changes the brain formation itself. Plans are personalized and may change over time as needs shift with growth or new symptoms. Drugs that target symptoms directly are called symptomatic treatments. Regular check-ins help balance benefits with side effects and keep doses right for weight and age.
Levetiracetam, oxcarbazepine, or valproate are commonly used to prevent seizures and reduce their intensity. Early symptoms of holoprosencephaly 11 can include seizures, so quick treatment may help protect development. Doctors may adjust doses after EEGs or if events change.
Hydrocortisone for adrenal insufficiency, levothyroxine for low thyroid, and somatropin (growth hormone) may be prescribed when tests show deficiencies. These replace missing hormones to support energy, growth, and temperature control. Blood tests guide dosing over time.
Desmopressin helps treat diabetes insipidus by reducing excessive urination and thirst. It can be given as a melt, nasal spray, or tablet, with fluids monitored closely. Sodium levels are checked to keep treatment safe.
Baclofen or diazepam can ease stiffness and spasms that make moving or caregiving harder. Botulinum toxin A injections may target specific tight muscles to improve comfort and positioning. Not everyone responds to the same medication in the same way.
Genetic influences
In many families, Holoprosencephaly 11 traces back to a change in a single gene that helps guide how the front of the brain forms early in pregnancy, often involving a gene called CDON. Having a gene change doesn’t always mean you will develop the condition. It often runs in families in a way where one altered copy can raise risk, yet the impact varies a lot—some parents who carry the change have very mild features or none at all. The same change can look different from one relative to another, and some cases appear for the first time in a child without any family history due to a new, not‑inherited change. Other influences—such as the mix of a person’s other genes and pregnancy factors like poorly controlled diabetes—can shape whether Holoprosencephaly 11 occurs and how severe it is. Genetic testing for Holoprosencephaly 11 can look for changes in CDON and related genes, which can help clarify recurrence risk for future pregnancies.
Is Holoprosencephaly 11 genetic?
Genetics plays a major role in Holoprosencephaly 11; many cases stem from changes in the SHH pathway genes, including heterozygous variants. Inherited and de novo variants both occur, with variable expressivity and incomplete penetrance. Genetic counseling and testing are often recommended.
Pharmacogenetics—how genetics influence drug effects
For Holoprosencephaly 11, medicines are chosen to manage features like seizures, feeding challenges, and hormone or salt–water balance problems; there isn’t a gene‑targeted drug yet. The specific genetic finding doesn’t point to one “best” medication, but it does guide doctors to watch for pituitary and electrolyte issues that can affect dosing and side effects. For seizure control, inherited differences in immune genes can raise the risk of rare but serious skin reactions with carbamazepine or oxcarbazepine, especially in people with an HLA type that’s more common in parts of Asia. Differences in drug‑processing enzymes may also change how much phenytoin or clobazam someone needs, and how quickly side effects show up. If diabetes insipidus or low sodium is part of Holoprosencephaly 11, medicines that can lower sodium (like oxcarbazepine) may require extra monitoring and careful dose changes. Pharmacogenetic testing can sometimes identify how your body breaks down specific anti‑seizure medicines, and your care team can use that information alongside your history to choose safer options.
Interactions with other conditions
Day to day, many children with Holoprosencephaly 11 need support for issues beyond brain development, including feeding, breathing, and hormone balance. Another important aspect is how it may link with other diseases. Holoprosencephaly 11 can occur on its own or as part of a broader genetic picture, and it sometimes appears with chromosomal conditions like trisomy 13, which bring heart, kidney, and limb differences. Even when chromosomes are typical, people with Holoprosencephaly 11 have higher rates of seizures, low blood sugar or salt problems from pituitary hormone issues, and cleft lip or palate, which can affect growth and sleep. Reflux, aspiration, and recurrent chest infections may interact with feeding challenges, while vision or hearing differences can shape early therapy needs. For families tracking early symptoms of Holoprosencephaly 11, it helps to ask how each new diagnosis—like epilepsy, thyroid or cortisol deficiency, or congenital heart disease—might change medications, nutrition, and safety planning.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies with closely spaced eyes, a single front tooth, or a small nose, not realizing these features could be connected. Families and midwives sometimes remembered a newborn who struggled to breathe or feed and did not survive long, while others recalled relatives with a mild facial difference who grew up and learned to adapt. These lived observations planted the earliest seeds of what we now recognize as holoprosencephaly 11.
First described in the medical literature as a problem of the developing forebrain, holoprosencephaly gradually came to include a wide spectrum—from severe forms seen at birth to much milder changes noticed later in childhood. Early reports focused on striking facial features and serious breathing or feeding difficulties. Over time, careful examinations, imaging, and longer-term follow-up showed that many living with holoprosencephaly 11 have less obvious findings, such as learning differences or subtle facial traits, underscoring how variable the condition can be.
As medical science evolved, autopsy studies from the early 20th century linked certain facial patterns with specific brain changes, helping doctors understand that the face and brain develop together during early pregnancy. The introduction of ultrasound and later MRI allowed these brain patterns to be seen in living infants, children, and even before birth. With each decade, the picture became clearer: the same underlying process can look very different from one person to another.
Advances in genetics in the late 20th and early 21st centuries identified several genes involved in forebrain and midline facial development. Researchers found that changes in these genes can act like a dimmer switch, turning developmental signals down to different degrees. This helped explain why one family member might have subtle features while another could have more serious brain differences. Holoprosencephaly 11 refers to one of these genetically defined forms, recognized when a specific gene change is found alongside compatible clinical features.
From early theories to modern research, the story of holoprosencephaly 11 shows how clinical observation, imaging, and genetics fit together. Not every early description was complete, yet together they built the foundation of today’s knowledge. Today, discussions of the condition include its full range—from early symptoms of holoprosencephaly 11 detected on prenatal scans to later recognition in a school-age child with mild learning challenges. This broader view has improved counseling, clarified risks for families, and opened the door to supportive care that better matches each person’s needs.